{"entity":{"id":"nct07554846","kind":"trial","name":"Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLC","aka":["ECTOP-1030"],"tldr":"A phase 3 trial in lung cancer, run by Fudan University, now recruiting.","summary":"Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLC is a phase 3, randomised interventional study registered as NCT07554846 by Fudan University, with a registry enrolment figure of 759 participants, started 2026-05-01 and due to reach its primary completion in 2030-05-01. Interventions recorded: Peroperative immunotherapy; Neoadjuvant immunotherapy; Adjuvant immunotherapy. Conditions listed: Resectable Stage II-IIIa NSCLC. Primary outcome: 3-year events-free survival (EFS) rate. Lung eligibility wording from the registry: \"Subjects with resectable stage II-IIIA non-small cell lung cancer (according to the AJCC 8th edition), without EGFR/ALK sensitive mutations, confirmed by histology or pathology;\". Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov NCT07554846","url":"https://clinicaltrials.gov/study/NCT07554846"}],"tags":["ctgov-ingest","lung-deep-dive"],"related":[],"cancers":["resectable-nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07554846","phase":"3","setting":"A Randomized, Open-label, Multicenter Phase III Clinical Trial Comparing Perioperative Immunotherapy to Adjuvant Immunotherapy or Neoadjuvant Immunotherapy With Toripalimab in Resectable Stage II-IIIA Non-small Cell Lung Cancer (ECTOP-1030)","sponsor":"Fudan University","enrolled":759,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07554846/","neighbours":{"cancer":[{"id":"resectable-nsclc","kind":"cancer","name":"Resectable stage I to III non-small-cell lung cancer","route":"/cancers/resectable-nsclc/"}],"term":[{"id":"lung-trials-open-today","kind":"term","name":"Lung cancer trials open today (registry snapshot)","route":"/terms/lung-trials-open-today/"}]}}